CHINARES PHARMA(03320),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

03320 CHINARES PHARMA

Market Closed 10-02 16:08:09

4.295

-0.155

-3.48%

High4.425	Low4.265	Vol4.78M
Open4.400	D1 Closing4.450	Amplitude3.60%
Mkt Cap26.99B	Tradable Cap26.98B	Total Shares6.28B
T/O20.55M	T/O Rate0.08%	Tradable Shares6.28B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"03320","market":"HK","secType":"STK","nameCN":"CHINARES PHARMA","latestPrice":4.295,"timestamp":1790928489006,"preClose":4.45,"halted":0,"volume":4782500,"delay":0,"changeRate":-0.034831460674157357,"floatShares":6282510461,"shares":6283000000,"eps":0.643391,"marketStatus":"Market Closed","change":-0.155,"latestTime":"10-02 16:08:09","open":4.4,"high":4.425,"low":4.265,"amount":20552058,"amplitude":0.035955,"askPrice":4.295,"askSize":2000,"bidPrice":4.29,"bidSize":11000,"shortable":3,"etf":0,"ttmEps":0.763522,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1791163800000},"marketStatusCode":7,"adr":0,"listingDate":1477584000000,"exchange":"SEHK","adjPreClose":4.45,"dividendRate":0.056917,"openAndCloseTimeList":[[1790904600000,1790913600000],[1790917200000,1790928000000]],"volumeRatio":0.8536589545357364,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/03320/tweets","defaultTab":"tweets","newsList":[{"id":"1193496544","title":"CHINARES PHARMA 1H26 Results: Revenue Rises 2.0 % to RMB134.46 B; Attributable Profit Up 5.3 %","url":"https://stock-news.laohu8.com/highlight/detail?id=1193496544","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193496544?lang=en_us&edition=fundamental","pubTime":"2026-09-24 08:23","pubTimestamp":1790209425,"startTime":"0","endTime":"0","summary":"China Resources Pharmaceutical Group Limited (CHINARES PHARMA) reported 1H26 revenue of RMB134.46 billion, a 2.0 % increase year-on-year. Gross profit edged up 0.1 % to RMB21.53 billion, while...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"CHINARES PHARMA 1H26 Results: Revenue Rises 2.0 % to RMB134.46 B; Attributable Profit Up 5.3 %","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03320"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664985338","title":"China Resources Pharma Unit's Bond Program Registration Accepted in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2664985338","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664985338?lang=en_us&edition=fundamental","pubTime":"2026-09-01 18:42","pubTimestamp":1788259361,"startTime":"0","endTime":"0","summary":"China Resources Pharmaceutical's  unit KPC Pharmaceuticals obtained registration acceptance for a proposed bond issue from the National Association of Financial Market Institutional Investors.The subsidiary can issue medium term bonds of up to 1 billion yuan in multiple tranches in China within two years of the notice, according to a Tuesday Hong Kong bourse filing.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["US2Y.BOND","TMF","BK1570","US3Y.BOND","TLTW","US7Y.BOND","US30Y.BOND","US6M.BOND","US12M.BOND","US5Y.BOND","03320","TLT","BK1191","US10Y.BOND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664830503","title":"China Resources Pharma Unit KPC Wins Registration to Issue RMB 1 Billion in Medium-Term Notes","url":"https://stock-news.laohu8.com/highlight/detail?id=2664830503","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664830503?lang=en_us&edition=fundamental","pubTime":"2026-09-01 17:49","pubTimestamp":1788256146,"startTime":"0","endTime":"0","summary":"China Resources Pharma unit KPC wins registration to issue RMB 1 billion in medium-term notesKPC Pharmaceuticals, an affiliate of China Resources Pharmaceutical, registered to issue medium term notes ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDL5X4cyB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0060","600422","BK1570","BK0239","BK0028","BK1191","03320","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664830527","title":"China Resources Pharmaceutical - Notice Issued by National Association of Financial Market Institutional Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2664830527","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664830527?lang=en_us&edition=fundamental","pubTime":"2026-09-01 17:48","pubTimestamp":1788256133,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nFWN44T0GP:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["03320","BK1570","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664542830","title":"China Resources Pharmaceutical Group - Kpc May Issue Medium Term Notes up to RMB1 Bln in Tranches over Two Years","url":"https://stock-news.laohu8.com/highlight/detail?id=2664542830","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664542830?lang=en_us&edition=fundamental","pubTime":"2026-09-01 17:48","pubTimestamp":1788256133,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nFWN44T0GP:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","BK1570","03320"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145118678","title":"CHINARES PHARMA: Subsidiary CR Pharmaceutical Holdings Posts 2% Revenue Growth, Stable Profit Ahead of PRC Debt Programme","url":"https://stock-news.laohu8.com/highlight/detail?id=1145118678","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145118678?lang=en_us&edition=fundamental","pubTime":"2026-08-31 18:23","pubTimestamp":1788171801,"startTime":"0","endTime":"0","summary":"China Resources Pharmaceutical Group Limited (abbrev. CHINARES PHARMA, HKEX: 03320) has released the unaudited financial statements of its wholly owned subsidiary, China Resources Pharmaceutical...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03320"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162469887","title":"China Resources Pharma's Core Arm Posts 3.13% Rise in First-Half Net Profit","url":"https://stock-news.laohu8.com/highlight/detail?id=1162469887","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162469887?lang=en_us&edition=fundamental","pubTime":"2026-08-31 18:16","pubTimestamp":1788171372,"startTime":"0","endTime":"0","summary":"China Resources Pharmaceutical Group Limited (SEHK: 03320), operating under the brand China Resources Pharma, has announced that its wholly-owned subsidiary, China Resources Pharmaceutical Holdings,...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","03320","BK1570"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663071755","title":"CR Pharmaceutical Holdings, China Resources Pharmaceutical Unit, Posts 1H Net Profit RMB 5.18 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2663071755","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663071755?lang=en_us&edition=fundamental","pubTime":"2026-08-31 18:05","pubTimestamp":1788170714,"startTime":"0","endTime":"0","summary":"CR Pharmaceutical Holdings, China Resources Pharmaceutical unit, posts 1H net profit RMB 5.18 billionChina Resources Pharmaceutical Holdings, a wholly owned subsidiary of China Resources Pharmaceutica","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDL6tjhbS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03320","BK1570","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662254007","title":"Earnings Miss: China Resources Pharmaceutical Group Limited Missed EPS By 12% And Analysts Are Revising Their Forecasts","url":"https://stock-news.laohu8.com/highlight/detail?id=2662254007","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662254007?lang=en_us&edition=fundamental","pubTime":"2026-08-27 06:09","pubTimestamp":1787782164,"startTime":"0","endTime":"0","summary":"As you might know, China Resources Pharmaceutical Group Limited ( HKG:3320 ) last week released its latest half-year...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3320/china-resources-pharmaceutical-group-shares/news/earnings-miss-china-resources-pharmaceutical-group-limited-m-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3320/china-resources-pharmaceutical-group-shares/news/earnings-miss-china-resources-pharmaceutical-group-limited-m-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["03320","VGFPF","BK1191","PMDE","RGLO","BK1570","FEBU","VOTE","JOYT","DECU","GXDW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150564848","title":"BofA Securities Trims China Resources Pharma Price Target to HK$5.7, Keeps Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=1150564848","media":"Stock News","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150564848?lang=en_us&edition=fundamental","pubTime":"2026-08-26 17:15","pubTimestamp":1787735753,"startTime":"0","endTime":"0","summary":"BofA Securities has issued a research report adjusting its price target for China Resources Pharma (03320) downward from HK$5.9 to HK$5.7, while reiterating a \"Buy\" rating on the stock.The firm noted...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03320","161027","BK1191","EWH","BK1570"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662567227","title":"China Resources Pharmaceutical Group (SEHK:3320) Stock Trades Cheap As Margin Recovery Seeks Credibility","url":"https://stock-news.laohu8.com/highlight/detail?id=2662567227","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662567227?lang=en_us&edition=fundamental","pubTime":"2026-08-25 22:23","pubTimestamp":1787667797,"startTime":"0","endTime":"0","summary":"China Resources Pharmaceutical Group stock closed at HK$4.65, capping a choppy few months in which the share price slipped over 5% in the past week and almost 1% over the past quarter. The market is still treating the company like a low-growth laggard with a P/E of about 6x, even as trailing net income from continuing operations reached ¥9.62b and net profit margin edged up to 1.5%.\nFor anyone looking beyond today’s tick-by-tick moves, this earnings release is really a story about valuation...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3320/china-resources-pharmaceutical-group-shares/news/china-resources-pharmaceutical-group-sehk3320-stock-trades-c","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3320/china-resources-pharmaceutical-group-shares/news/china-resources-pharmaceutical-group-sehk3320-stock-trades-c","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1191","03320","BK1570"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163986798","title":"CHINARES PHARMA declares RMB 0.087 interim dividend for H1 2026; payment set for 30 October 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1163986798","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163986798?lang=en_us&edition=fundamental","pubTime":"2026-08-24 16:47","pubTimestamp":1787561235,"startTime":"0","endTime":"0","summary":"China Resources Pharmaceutical Group Limited (CHINARES PHARMA) has announced an interim ordinary dividend of RMB 0.087 per share for the six months ended 30 June 2026. The payout corresponds to HKD...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03320"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114343490","title":"CHINARES PHARMA Posts Stable 1H26 Results; Revenue Rises to RMB 134.46 Billion, Interim Dividend Up 21%","url":"https://stock-news.laohu8.com/highlight/detail?id=1114343490","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114343490?lang=en_us&edition=fundamental","pubTime":"2026-08-24 16:47","pubTimestamp":1787561227,"startTime":"0","endTime":"0","summary":"China Resources Pharmaceutical Group Limited (CHINARES PHARMA) released its unaudited results for the six months ended 30 June 2026, showing modest top-line growth and resilient profitability amid a...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"CHINARES PHARMA Posts Stable 1H26 Results; Revenue Rises to RMB 134.46 Billion, Interim Dividend Up 21%","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03320"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107833077","title":"China Resources Pharma Reports 5.3% Rise in Interim Net Profit to HK$2.187 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1107833077","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107833077?lang=en_us&edition=fundamental","pubTime":"2026-08-24 16:44","pubTimestamp":1787561066,"startTime":"0","endTime":"0","summary":"China Resources Pharmaceutical Group Limited (03320) has announced its interim results for the six months ended June 30, 2026, revealing revenue of HK$134.4576 billion, representing a 2% year-on-year...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1570","03320","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164133149","title":"China Resources Pharmaceutical Sets October 30 Payout for Interim Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=1164133149","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164133149?lang=en_us&edition=fundamental","pubTime":"2026-08-24 16:38","pubTimestamp":1787560691,"startTime":"0","endTime":"0","summary":"China Resources Pharmaceutical (03320) has announced the distribution of its interim dividend for the six-month period ended June 30, 2026.The company will disburse a dividend of HKD 0.1006 per share...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EWH","BK4588","BK1191","VIG","BK1570","BK4585","03320"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661460221","title":"China Resources Pharmaceutical Group Declares Interim Dividend of Rmb0.087 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2661460221","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661460221?lang=en_us&edition=fundamental","pubTime":"2026-08-24 16:33","pubTimestamp":1787560430,"startTime":"0","endTime":"0","summary":"BRIEF-China Resources Pharmaceutical Group Declares Interim Dividend Of RMB0.087 Per ShareAug 24  - China Resources Pharmaceutical Group H1 net income attributable RMB 2,186.6 million.China Resources Pharmaceutical declared an interim dividend of RMB0.087 per shareH1 revenue RMB 134,457.6 million","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nPLXZF64Q4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1570","03320","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661221127","title":"China Resources Pharmaceutical Declared an Interim Dividend of Rmb0.087 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2661221127","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661221127?lang=en_us&edition=fundamental","pubTime":"2026-08-24 16:31","pubTimestamp":1787560289,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nPLXZF64Q4:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["03320","BK1570","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661221103","title":"China Resources Pharmaceutical Group H1 Revenue RMB 134,457.6 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2661221103","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661221103?lang=en_us&edition=fundamental","pubTime":"2026-08-24 16:31","pubTimestamp":1787560289,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nPLXZF64Q4:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["03320","BK1570","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661299276","title":"China Resources Pharmaceutical Group Says HY Revenue RMB 1.93 Billion for CR Jiangzhong","url":"https://stock-news.laohu8.com/highlight/detail?id=2661299276","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661299276?lang=en_us&edition=fundamental","pubTime":"2026-08-21 23:22","pubTimestamp":1787325774,"startTime":"0","endTime":"0","summary":"BRIEF-China Resources Pharmaceutical Group Says HY Revenue RMB 1.93 Billion For CR JiangzhongAug 21 -China Resources Pharmaceutical Group Ltd3320.HK:HY REVENUE RMB 1.93 BILLION, DOWN 9.75% FOR CR JIANGZHONGSIX-MONTH NET PROFIT ATTRIBUTABLE TO SHAREHOLDERS RMB 491.4 MILLION, DOWN 5.92% FOR CR JIANGZHONGCR JIANGZHONG PROPOSED TO DISTRIBUTE CASH DIVIDEND OF RMB5 FOR EVERY 10 SHARESFurther company coverage:3320.HK","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nFWN44H1R4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0028","BK0175","BK1570","03320","BK0188","600750","BK1191","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169613570","title":"KPC Pharmaceuticals Posts H1 2026 Net Loss of RMB 0.36 Billion as Revenue Falls 51%","url":"https://stock-news.laohu8.com/highlight/detail?id=1169613570","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169613570?lang=en_us&edition=fundamental","pubTime":"2026-08-21 19:28","pubTimestamp":1787311704,"startTime":"0","endTime":"0","summary":"China Resources Pharmaceutical Group Limited (CHINARES PHARMA, 03320) announced that its 29.08%-owned subsidiary KPC Pharmaceuticals (KPC) recorded a sharp downturn in interim results for the six...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03320"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.crpharm.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":-0.0037},{"period":"3month","weight":-0.0236},{"period":"6month","weight":-0.2778},{"period":"1year","weight":-0.0606},{"period":"ytd","weight":0.0175}],"compareEarnings":[{"period":"1week","weight":-0.0219},{"period":"1month","weight":-0.0529},{"period":"3month","weight":0.0266},{"period":"6month","weight":-0.0456},{"period":"1year","weight":-0.1215},{"period":"ytd","weight":-0.0647}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"China Resources Pharmaceutical Group Ltd is an investment holding company principally engaged in the pharmaceutical business. The Company operates its business through four segments. The Pharmaceutical Business segment develops, manufactures and sells a range of pharmaceuticals and health products. The Pharmaceutical Distribution Business segment provides distribution, warehousing, logistics and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers, device manufacturer and dispensers, including hospitals, distributors and retail pharmacies. The Pharmaceutical Retail Business segment operates retail pharmacies. The Other Business Operations segment engages in property holding and other businesses.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.012707},{"month":2,"riseRate":0.7,"avgChangeRate":0.04534},{"month":3,"riseRate":0.5,"avgChangeRate":0.003155},{"month":4,"riseRate":0.7,"avgChangeRate":0.030364},{"month":5,"riseRate":0.5,"avgChangeRate":0.000616},{"month":6,"riseRate":0.3,"avgChangeRate":-0.002096},{"month":7,"riseRate":0.3,"avgChangeRate":-0.023787},{"month":8,"riseRate":0.4,"avgChangeRate":-0.009791},{"month":9,"riseRate":0.4,"avgChangeRate":-0.016796},{"month":10,"riseRate":0.2,"avgChangeRate":-0.027879},{"month":11,"riseRate":0.4,"avgChangeRate":0.010199},{"month":12,"riseRate":0.5,"avgChangeRate":-0.000983}],"exchange":"SEHK","name":"CHINARES PHARMA","nameEN":"CHINARES PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CHINARES PHARMA(03320),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest CHINARES PHARMA(03320) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"CHINARES PHARMA,03320,CHINARES PHARMA股票,CHINARES PHARMA股票老虎,CHINARES PHARMA股票老虎国际,CHINARES PHARMA行情,CHINARES PHARMA股票行情,CHINARES PHARMA股价,CHINARES PHARMA股市,CHINARES PHARMA股票价格,CHINARES PHARMA股票交易,CHINARES PHARMA股票购买,CHINARES PHARMA股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CHINARES PHARMA(03320),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest CHINARES PHARMA(03320) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}